Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Other Income/Expenses (Net)
$10.47M
Quarterly · Period ending: · USD
LCTX Other Income/Expenses (Net)
Latest reported$10.47Mperiod ending
Latest reported$10.47Mperiod ending
LCTX Quarterly Other Income/Expenses (Net) ($0.00 → $10.47M)
Quarterly Other Income/Expenses (Net)
High-resolution chart · PNG
LCTX other income/expenses (net) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| 10,467,000 | |
| 2,804,000 | |
| 2,160,000 | |
| -25,966,000 | |
| -10,584,000 | |
| 2,362,000 | |
| 1,860,000 | |
| 839,000 | |
| 94,000 | |
| 103,000 | |
| 1,648,000 | |
| -453,000 | |
| -179,000 | |
| 435,000 | |
| 277,000 | |
| -324,000 | |
| -2,548,000 | |
| -697,000 | |
| 229,000 | |
| -2,003,000 | |
| 2,115,000 | |
| 5,602,000 | |
| 6,866,000 | |
| -1,225,000 | |
| -128,000 | |
| -990,000 | |
| 1,532,000 | |
| -9,084,000 | |
| -20,479,000 | |
| 47,673,000 | |
| -35,115,000 | |
| 76,901,000 | |
| 4,498,000 | |
| -51,511,000 | |
| -67,281,000 | |
| 28,271,000 | |
| -5,786,000 | |
| 62,163,000 | |
| 3,513,000 | |
| 38,820,000 | |
| 35,628,000 | |
| -239,000 | |
| 3,774,000 | |
| -585,000 | |
| 229,000 | |
| -264,937 | |
| -574,403 | |
| -126,000 | |
| 155,000 | |
| 60,786 | |
| -42,276 | |
| -54,365 | |
| -79,162 | |
| -28,636 | |
| -78,031 | |
| 22,939 | |
| 81,714 | |
| -318,797 | |
| 74,122 | |
| 494,739 | |
| 703,066 | |
| 663,755 | |
| -3,620,792 | |
| 2,457,704 | |
| 55,649 | |
| 39,358 | |
| 13,975 | |
| -640,414 | |
| -363,720 | |
| -606,959 | |
| 968,023 | |
| -163,341 | |
| 286,556 | |
| -68,976 | |
| 257,395 | |
| -57,825 | |
| -50,279 | |
| -38,230 | |
| 340,123 | |
| -30,545 | |
| -26,664 | |
| -17,116 | |
| 51,120 | |
| -11,358 | |
| -15,560 | |
| -1,064 | |
| 1,803 | |
| 13,415 | |
| 5,676 | |
| -1,137,444 | |
| 8,464 | |
| 719,342 | |
| -259,478 | |
| -205,447 | |
| 609,000 | |
| -261,267 | |
| -209,893 | |
| 0 | |
| 0 | |
| 0 |